A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult Subjects

NCT03486236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: VX-440
DRUG: TEZ
DRUG: IVA
DRUG: Matched Placebos

Sponsor

Vertex Pharmaceuticals Incorporated